Randomized study of low‐dose versus standard‐dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|4|407-412

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.4, 2015-04, pp. : 407-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1414-1420

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II trial of chemoradiotherapy with S‐1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)

By  

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 726-733

John Wiley & Sons Inc

Access to resources Recommend Favorite

HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3

By  

Cancer Science, Vol. 109, Iss. 2, 2018-02 ,pp. : 317-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma

By  

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1118-1129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma

By  

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1118-1129

John Wiley & Sons Inc

Access to resources Recommend Favorite